← Back to Patent Explorer
US3989840A Expired / Lapsed US ⏱️ 0.0 years remaining

Control of animal parasites with ring-substituted N-(2,2-difluoroalkanoyl)-O-phenylenediamines

Assignee: Eli Lilly and Co
•
Filing: 1975-07-18
•
Granted: 1976-11-02
•
Expires: 1995-07-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A class of substituted o-phenylenediamines are useful parasiticides for the systemic control of insects and acarina which feed on tissues of animals. The compounds, which control both bloodsucking parasites and flesh-eating parasites, are characterized by a single nitro substituent on the benzene ring, and a single fluoroalkyl or chlorodifluoroalkyl substituent on the benzene ring.

Inventors

  • 👤 George Oliver Plunkett O'Doherty

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 23:31
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/16; A61K31/165; A61K31/21; A61K31/27

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 213 words
A method of killing insect and acarina parasites which consume living tissues of a host animal which comprises orally or percutaneously administering to the host animal a parasiticidally-effective amount of a compound of the formula: ##SPC10## wherein R° is a 2,2-difluoroalkanoyl radical of the formula ##EQU1## in which Y is hydrogen, chlorine, fluorine, difluoromethyl, perfluoroalkyl of C 1 -C 6 , or a radical of the formula ##EQU2## in which each Z independently is hydrogen or halogen and n is 0 or 1; R 1 is R°, hydrogen, a radical of the formula ##EQU3## in which Y 1 is C 1 -C 4 alkyl or phenyl, C 1 -C 8 alkanoyl, benzoyl, furoyl, naphthoyl, or substituted benzoyl of the formula ##SPC11## in which each Z' independently is halo or nitro, Z" is C 1 -C 4 alkyl or C 1 -C 4 alkoxy, p is 0, 1, or 2, q is 0 or 1, and the sum of p and q is 1-3; R 2 is trifluoromethyl, difluoromethyl, or chlorodifluoromethyl, and the nitro group and R 2 are meta to one another; and subject to the further limitation that where R 1 is hydrogen, the ring position ortho to the --NH--R 1 group bears one of the designated nitro or R 2 moieties.
Claim 2
Independent Claim 213 words
A method of killing insect and acarina parasites which consume living tissues of a host animal which comprises orally or percutaneously administering to the host animal a parasiticidally-effective amount of a compound of the formula: ##SPC10## wherein R° is a 2,2-difluoroalkanoyl radical of the formula ##EQU1## in which Y is hydrogen, chlorine, fluorine, difluoromethyl, perfluoroalkyl of C 1 -C 6 , or a radical of the formula ##EQU2## in which each Z independently is hydrogen or halogen and n is 0 or 1; R 1 is R°, hydrogen, a radical of the formula ##EQU3## in which Y 1 is C 1 -C 4 alkyl or phenyl, C 1 -C 8 alkanoyl, benzoyl, furoyl, naphthoyl, or substituted benzoyl of the formula ##SPC11## in which each Z' independently is halo or nitro, Z" is C 1 -C 4 alkyl or C 1 -C 4 alkoxy, p is 0, 1, or 2, q is 0 or 1, and the sum of p and q is 1-3; R 2 is trifluoromethyl, difluoromethyl, or chlorodifluoromethyl, and the nitro group and R 2 are meta to one another; and subject to the further limitation that where R 1 is hydrogen, the ring position ortho to the --NH--R 1 group bears one of the designated nitro or R 2 moieties.
Claim 3
Dependent Claim 22 words
The method of claim 1 in which the compound is of the formula ##SPC12## wherein R° is defined as in claim 1.
Claim 4
Dependent Claim 13 words
The method of claim 1 in which the compound is N 1 -trifluoroacetyl-3'-nitro-5'-trifluoromethyl-o-phenylenediamine.
Claim 5
Dependent Claim 13 words
The method of claim 1 in which the compound is N 1 -(2,2,3,3-tetrafluoropropionyl)-3'-nitro-5'-trifluoromethyl-o-phenylenediamine.
Claim 6
Dependent Claim 13 words
The method of claim 1 in which the compound is N 1 -trifluoroacetyl-3'-trifluoromethyl-5'-nitro-o-phenylenediamine.
Claim 7
Dependent Claim 13 words
The method of claim 1 in which the compound is N 1 -chlorodifluoroacetyl-3'-nitro-5'-trifluoromethyl-o-phenylenediamine.
Claim 8
Dependent Claim 15 words
The method of claim 1 in which the compound is N 1 -trifluoroacetyl-N 2 -benzoyl-6'-nitro-4'-trifluoromethyl-o-phenylenediamine.
Claim 9
Dependent Claim 15 words
The method of claim 1 in which the compound is N 1 -trifluoroacetyl-N 2 -naphthoyl-6'-nitro-4'-trifluoromethyl-o-phenylenediamine.
Claim 10
Dependent Claim 15 words
The method of claim 1 in which the compound is N 1 -trifluoroacetyl-N 2 -(p-n-butoxybenzoyl)-4'-trifluoromethyl-6'-nitro-o-phenylenediamine.
Claim 11
Dependent Claim 15 words
The method of claim 1 in which the compound is N 1 -trifluoroacetyl-N 2 -(p-nitrobenzoyl)-4'-trifluoromethyl-6'-nitro-o-phenylenediamine.
Claim 12
Dependent Claim 13 words
The method of claim 1 in which the compound is N 1 -heptafluorobutyryl-3'-nitro-5'-trifluoromethyl-o-phenylenediamine.
Claim 13
Dependent Claim 13 words
The method of claim 1 in which the compound is N 1 -pentafluoropropionyl-3'-nitro-5'-trifluoromethyl-o-phenylenediamine.
Claim 14
Dependent Claim 15 words
The method of claim 1 in which the compound is N 1 -trifluoroacetyl-N 2 -methoxycarbonyl-4'-trifluoromethyl-6'-nitro-o-phenylenediamine.
Claim 15
Dependent Claim 13 words
The method of claim 1 in which the compound is N 1 -pentadecafluorooctanoyl-3'-nitro-5'-trifluoromethyl-o-phenylenediamine.
Claim 16
Dependent Claim 15 words
The method of claim 1 in which the compound is N 1 -(2,2,3,3-tetrafluoropropionyl)-N 2 -methoxycarbonyl-6'-nitro-4'-trifluoromethyl-o-phenylenediamine.
Claim 17
Dependent Claim 11 words
The method of claim 1 in which the compound is N-(pentafluoropropionyl)-3'-nitro-5'-trifluoromethyl-o-phenylenediamine.
Claim 18
Dependent Claim 24 words
The method of claim 1 in which from about 1 mg./kg. to about 100 mg./kg. of the compound is administered to the host animal.
Claim 19
Dependent Claim 24 words
The method of claim 17 in which from about 2.5 mg./kg. to about 50 mg./kg. of the compound is administered to the host animal.
Claim 20
Dependent Claim 11 words
The method of claim 17 in which the administration is percutaneous.
Claim 21
Dependent Claim 14 words
The method of claim 19 in which the compound is administered in an implant.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-11-02 1980-05-03 1980-11-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-11-02 1984-05-03 1984-11-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-11-02 1988-05-03 1988-11-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag